Atlas Trials

A Study of HH-120 Nasal Spray in Close Contacts of Those Diagnosed With COVID-19

Clinical trial NCT05747677 · COMPLETED

Trial details

NCT number
NCT05747677
Sponsor
Beijing Ditan Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19SARS-CoV-2 Infection
Start date
2022-06-14
Primary completion
2023-02-06
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.